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MammoWave is a microwave imaging device for breast lesions detection, which operates using two 
(azimuthally rotating) antennas without any matching liquid. Images, subsequently obtained by resorting to 
Huygens Principle, are intensity maps, representing the homogeneity of tissues’ dielectric properties. 
In this paper, we propose to generate, for each breast, a set of conductivity weighted microwave images by 
using different values of conductivity in the Huygens Principle imaging algorithm. Next, microwave images’ 
parameters, i.e. features, are introduced to quantify the non-homogenous behaviour of the image. We 
empirically verify on 103 breasts that a selection of these features may allow distinction between breasts 
with no radiological finding (NF) and breasts with radiological findings (WF), i.e. with lesions which may be 
benign or malignant. Statistical significance was set at p<0.05. We obtained single features Area Under the 
receiver operating characteristic Curves (AUCs) spanning from 0.65 to 0.69. In addition, an empirical rule-
of-thumb allowing breast assessment is introduced using a binary score S operating on an appropriate 
combination of features. Performances of such rule-of-thumb are evaluated empirically, obtaining a 






Mammography is the gold standard technology for mammographic screening, which has been demonstrated 
through different randomized controlled trials (RCTs) [1, 2, 3] to reduce breast cancer mortality. However, it 
has some limitations and potential harms, such as the use of ionizing radiation, breast compression and 
performance restrictions due to the intrinsic nature of x-rays. In particular, breast density is a restrictive 
property that can prevent breast cancer detection in mammograms of women with radiographically dense 
breasts [4, 5]. In general, women are eligible for biannual screening after the age of 49 in order to minimize 
the impact of ionizing radiation. Nevertheless, recent studies estimate that breast cancer is diagnosed in 6.6% 
of women below the age of 40 [4], and an average of 20% of breast cancer cases in Europe occur in women 
when they are younger than 50 years old [6]. 
Many efforts are being done to develop non-ionizing technologies which could allow to carry out screening 
with neither age nor follow-up examination interval restrictions. In this context, microwave imaging appears 
as a promising technology for breast lesions detection [7]. Microwave imaging methods are developed to 
discriminate between healthy tissues and tissues with lesions by exploiting their contrast in dielectric 
properties, i.e. permittivity and conductivity, within the spectrum of microwave frequencies. A high contrast 
(up to 5) has been reported [7] between healthy breast tissue and malignant tissue, while newer studies 
confirm a high contrast only between fatty and malignant breast tissues, while it decreases between healthy 
fibro glandular and malignant tissues [8, 9]. 
Microwave imaging techniques may be classified into two main groups: microwave tomography and ultra-
wideband (UWB) radar methods [10]. Microwave tomography is based on inverse scattering algorithms that 
create maps of permittivity and conductivity; however, inverse scattering approaches could suffer from 
mathematical instability, which may not converge to a meaningful solution. UWB radar methods instead 
perform a linear reconstruction of the image, which is a scattering map in arbitrary units.  
The exploitation of both microwave imaging techniques has led to the construction of different prototypes, 
which may differ in hardware and imaging algorithm, i.e., software. Some prototypes are being tested at 
clinical level: a quite complete review of prototypes at clinical level can be found in [11].  
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One of these prototypes, Maria system, uses an array of 60 antennas and a matching liquid to carry out radar 
approach [12] with a sensitivity of 76% [13].  
Among prototypes at clinical level, MammoWave requires to operate just two (azimuthally rotating) 
antennas without any matching liquid, i.e. antennas and breast are in free space. MammoWave has an 
innovative frequency domain imaging algorithm which is based on Huygens Principle (HP) [14]. This device 
has been presented, tested and clinically validated [15-17]. Images obtained using the proposed apparatus are 
intensity maps, given in linear arbitrary units, representing the homogeneity of tissues’ dielectric properties. 
In this paper, we propose to generate, for each breast, a set of microwave images by using different values of 
conductivity in the HP imaging algorithm, i.e. conductivity weighted microwave images. Next, microwave 
images’ parameters, i.e. features, are calculated to quantify and measure the non-homogenous behaviour of 
the image. We show that an appropriate selection of image features may allow distinction between breasts 
with no radiological finding (NF), and breasts with radiological findings (WF), i.e. with lesions which may 
be benign or malignant. In addition, we show that an appropriate combination and use of image features may 
allow performance enhancement. The procedure has been empirically verified on 103 breasts, each one with 




Materials and Methods 
Microwave apparatus and imaging algorithm 
The MammoWave system, shown in Figure 1 (top left), consists of an aluminum cylindrical hub 
containing two antennas, one transmitting (tx) and one receiving antenna (rx), which operate in the 1-9 GHz 
frequency band. The hub is internally covered by microwave absorbers. The hub is equipped with a hole with 
a cup, allowing the insertion of the patient’s breast, with the patient lying in a prone position. The antennas 
are installed at the same height, in free space and are able to rotate around the azimuth in order to collect the 
microwave signals from different angular positions. More details can be found in [15]. The tx and rx are 
connected to a 2-port VNA (Cobalt C1209, Copper Mountain, Indianapolis, IN) which operates up to 9 GHz. 
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Measurements have been performed recording the complex S21 in a multi-bistatic fashion, i.e. for each 
transmitting position txm the receiving antenna is moved to measure the received signal every 4.5°, leading to 
a total of 80 receiving points rxnp. Concerning the transmitting positions, all the experiments have been done 
by employing 10 transmitting position, displaced in 5 sections centered at 0°, 72°, 144°, 216°, and 288°. 
Figure 1 illustrates the set-up configuration. As Figure 1 (right) shows, in each section the transmitting 
positions may be displaced by 9°. For each transmitting and receiving position, the complex S21 is collected 
from 1 to 9 GHz, with 5 MHz sampling.  
Assuming that rx can be rotatably moved to measure the received signal at the points 0rx ( , )np np npa   

 
displaced along a circular surface having radius a0, the received signals can be expressed as 
,
0 ,21 ( , ; tx ; )
m p
n n m pS a f , where n=1,2,…,80, indicates the receiving points; m=1,2…,5 indicates the 
transmitting sections, p=1,2 and p’=1,2 indicate the position inside each transmitting section; and f is the 
frequency. The received signals are then processed through HP to calculate the field inside the cylinder; such 
field is then used to generate an image, which is a homogeneity map of dielectric properties. To remove the 
artefacts [18], here we employ the subtraction between S21 obtained using two measurements belonging to 
the doublet of the same section. In formula: 
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where (   is the observation point,  is the spatial sampling. k1 indicates the wave number, and G is 
the Green’s function. The “reconstructed” internal field has been indicated by the string rcstr while the string 
HP indicates that Huygens based procedure will be employed in eq. (1). Note that, if the conductivity of the 
media is not equal to zero, eq. (1) compensates the attenuation experienced when going into the media. 
Assuming we use NF frequencies if  in the band B, it follows that the intensity of the image I may be obtained 
through the following equation, i.e. by summing incoherently all the solutions of all the sections: 
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Figure 1. The MammoWave system (top left), consists of an aluminum cylindrical hub containing two antennas, one transmitting 
and one receiving antenna. The hub is equipped with a hole with a cup, allowing the insertion of the patient’s breast, with the patient 
lying in a prone position (bottom left). The antennas are installed at the same height, in free space and are able to rotate around the 
azimuth in order to collect the microwave signals from different angular positions (right). 
 
In-vivo validation 
In-vivo validation of MammoWave on volunteers in Perugia Hospital and Foligno Hospital was approved 
in 2015 by the Ethical Committee of Umbria, Italy (N. 6845/15/AV/DM of 14/10/2015, N. 10352/17/NCAV 
of 16/03/2017, N 13203/18/NCAV of 17/04/2018). The protocol concerns a feasibility study for detection of 
breast lesion using the proposed microwave mammogram apparatus, with the aim of quantifying the 
potential of the proposed microwave mammogram apparatus to be used for medical technology screening. 
The inclusion criteria allowed female volunteers above 18 years old with intact breast skin and with a 
radiologist study output obtained through conventional exams (mammography and/or ultrasound and/or 
magnetic resonance imaging) within the last month.  All protocols and procedures were in accordance with 
both institutional and national ethical standards in research, and with World Medical Association Declaration 
of Helsinki (1964) and its later amendments or analogous ethical standards. Prior to the trial, all participants 
have been requested to read and sign both the informative sheet and informed consent form.  
We present here the results obtained using a set of data constituted of 103 breasts. Each breast has its own 
correspondent output of the radiologist study review, which has been used as gold standard for classification 
of the breasts in two categories: breasts with no radiological finding (NF), and breasts with radiological 
findings (WF), i.e. with lesions which may be benign or malignant. In this context, radiological study 
examination included: mammography, performed using Selenia LORAD Mammography System (Hologic, 
Marlborough, MA), and/or echography, performed using the MyLab 70 xvg Ultrasound Scanner (Esaote, 
Genova, Italy), and/or magnetic resonance imaging, performed through a 3.0 T MAGNETOM scanner 
(Siemens Healthcare, Erlangen, Germany). In addition, where possible, the breast type has been classified 
according to its density, following the scale defined by the American College of Radiology (ACR) which 
goes from ACR A (almost entirely fatty breasts) to ACR D (extremely dense breasts, which lowers the 
sensitivity of mammography) [18]. Some details of the detected or suspected lesions have also been collected 
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[19-21]. Moreover, lesions’ final assessment (benign/malignant) has been performed using pathology and/or 
at least one year of clinical follow-up as reference standards. 
Once a subject agrees to participate, she is assisted by the clinical study coordinator; the subject (prone) 
positions her breast in the cup, which is appropriately integrated in a bed as shown in Figure 1 (bottom left). 
Specifically, three cups having varying sizes are available, and the clinical study coordinator chose the one 
that better fits the subject’s breast. Cups are made of polylactic acid (PLA), which has proven to be 
biocompatible [22]. The thickness of the cup is 1 mm; it has been shown that such thickness does not impact 
microwave imaging [16]. 
It is worthwhile pointing out that no matching liquid is used in the apparatus, and no breast compression has 
to be applied during acquisition.  
Microwave images have been first obtained in a cylindrical grid having radius equal to 7 cm (which 
corresponds to the radius of the receiving antenna), a radial sampling of 1 mm and an azimuthal sampling of 
3°. Next, all images have been interpolated on a 2D Cartesian grid having X and Y sampling of 1 mm.  
Due to the presence of receiving antenna in free space, the images have been obtained using free space 
dielectric constant in eq. (1). Instead, concerning the conductivity, for each breast we produced ten different 
microwave images, i.e. we apply a conductivity weighing by varying the conductivity (denoted with σ) from 
0 to 0.9 S/m with a sampling of 0.1 S/m when applying eq. (1). We will refer to such microwave images as 
conductivity weighted microwave images (MI), and they will be referred to as MI . 
MammoWave acquisition time is approximately 10 minutes (per breast); acquisition is made just once, and 
then the set of conductivity weighted microwave images is produced. Images obtained using the proposed 
apparatus are intensity maps, given in linear arbitrary units, representing the homogeneity of tissues’ 
dielectric properties. To allow inter and intra-subject comparison, all images are normalized to unitary 
average of the intensity.  
 
Feature Extraction 
For allowing a quantification of the non-homogenous behaviour of the microwave images, we introduce the 
following parameters, i.e. features: 
MIN = Minimum value of the image; 
8 
 
MAX = Maximum value of the image; 
MEA= Mean value of the image; 
MED= Median value of the image; 
VAR = Variance of the image; 
MAD0 = Mean absolute deviation of the image; 
MAD1 = Median absolute deviation of the image; 
KUR = Kurtosis of the image (given by the average value of the two projections in Cartesian grid); 
SKE = Skewness of the image (given by the average value of the two projections in Cartesian grid); 
M2AVG=(MAX) / (MEA); 
ROS1 = (MAX-MIN) / (MEA-MIN); 
ROS2 = (MAX-MIN) / (MED-MIN); 
ENT = Entropy of the image. 
For each conductivity weighted image, the previous features are calculated on the full domain of the image, 
i.e.  MI full imagefeature    , where they are denoted with the subscript “_i”. In addition, for each conductivity 
weighted image, all the features listed above excluding KUR, SKE, ROS1, ROS2 are calculated: on the peak 
region (a region which is centered in the maximum of the image and it extends to MAX/√2), i.e. 
MIpeakfeature    , where they are denoted with the subscript “_p” ; and on its complementary, i.e. 
MIcomplfeature    , where they are denoted with the subscript “_c”. The ratios between features calculated on 
the peak region and on its complementary are considered as added features, and they are denoted with the 
subscript “_r”. To summarize, we denote with  MIfeature   the set of all features of each conductivity 
weighted image. 
Next, for each feature, using the gold standard output of the radiological study review (in which breasts have 
been classified in two categories, NF breasts and WF breasts), we calculate: the mean and standard deviation 
for the NF breasts, and the mean and standard deviation for the WF breasts.  
In addition, for each feature, using the gold standard output of the radiological study review, Welch's t-test 
(i.e. a two-sample two-tailed unpooled variances t-test) with α = 0.05 has been performed. Statistical 
significance was set at p<0.05. We also numerically evaluated the receiver operating characteristic (ROC): 
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specifically, for each feature (of each conductivity weighted image), we evaluated True Positive (TP) and 
False Negative (FN) rates. In more details, since TP rate and FN rate depend on the classifier threshold, i.e. 
the decision offset, we empirically calculated ROC curves by adjusting the decision offset and calculating TP 
and FN for all possible decision offsets. The area under the curve (AUC) is determined.  
 
Feature Selection and Calculations 
With the aim of empirically verifying if an appropriate selection and combination of microwave image 
features may allow discriminating between NF and WF breasts, the following steps are performed for each 
conductivity weighted image: 
i) for the ROC of each feature, the TP rate obtained for True Negative (TN) rate TN=0.55, i.e. TP|TN=0.55 , is 
calculated, and the corresponding decision offset is annotated, i.e.   MIoffsetD feature  ; 
ii) we order the feature with decreasing TP|TN=0.55 and we select the first four (after checking that p<0.05 is 
verified); 
iii) we calculate the average of TP|TN=0.55 on the first four features, i.e.  5 0.55|best TNmean TP  . 
Then, we order the conductivity weighed images with decreasing  5 0.55|best TNmean TP   and we select the 
first five.  In addition, for each breast and for all selected conductivity weighed image features, we introduce 
a binary score S defined as follows: 
    
    
if   MI MI
if 
,  then S
M
=1












.    (3) 
The binary score S is then used for establishing an empirical rule-of-thumb allowing assessment of 
conductivity weighed images. Specifically: 
if a conductivity weighed image has a number of occurrences of S=1 greater than M, then the 
conductivity weighed image is annotated as positive; 
if a breast has at least N positive conductivity weighed images, such breast is annotated as positive. 
Performances of the proposed rule-of-thumb may be evaluated by empirically calculating the TP rate, i.e. 
sensitivity, and TN rate, i.e. specificity, by adjusting the decision thresholds M and N. As an example, 





According to the radiologist study review, a total number of 52 NF (19 dense, i.e. ACR density C and D) and 
51 WF (22 dense, i.e. ACR density C and D) breasts were analyzed. The summary of the patient population 
used in this study is shown in Table 1, while the summary of the radiological study review is given in Table 
2. In Table 3, some details of the radiologist study review are given for the 51 WF breasts. Lesions’ final 
assessment, performed using pathology and/or at least one year of clinical follow-up as reference standards, 
leads to 30 benign and 17 malignant lesions, while in 4 cases the final assessment is not available.   
The selected features for the selected conductivity weighed images are listed in Table 4. For each feature, we 
indicate: the mean and standard deviation for the NF breasts; the mean and standard deviation for the WF 
breasts; the decision offset corresponding to TN=0.55; Welch's t-test score and p-value; the AUC.  ROC 
curves of the selected features are shown in Figure 2. 
 
 
Figure 2. ROC curves of the selected features for the selected conductivity weighed images; the value of the correspondent 
conductivity (expressed in S/m) is given above each figure. 
 
 
Table 1. Summary of the patient population used in this study. 
 
Total number of patients included in this study 58 
Total number of breasts included in this study* 103 
Average age  of the  patients included in this study 52 
Number of patients having age 20-49  27 
Number of patients having age 50-80  31 






Table 2. Summary of radiological study review for the breasts considered in this study. 
In the brackets, the number of dense breasts, i.e. ACR C and ACR D, is given. 
 TOT 
 
NF breasts 52 (19) 






Table 3. Details of the radiological study review are given for the 51 WF breasts: age, left (L) or right (R) breast, ACR breast 
density, mammography/echography BI-RADS, radiologist’s output details such as sizes (mm) and notes (if available), final 
assessment (Benign/Malignant) obtained using pathology and/or at least one year of clinical follow-up as reference standards (if 












Radiologist’s output details:  sizes (mm) 
and notes (if available) 




48 L D 3 - Microcalcifications Benign Positive 
65 L C 4 - Cluster of microcalcifications Benign Positive 
40 
L B 2 2   Three masses: 15 mm, 21 mm and 23 mm Benign Positive 
R B 2 2   Microcalcifications Not available Positive 
52 L C 5 - Microcalcifications Malignant Positive 
47 L D 2 2 Microcalcifications Benign Negative 
55 
R C 2 2 1.6 mm  microcalcifications Benign Positive 
L C 2 2  3.8 mm  microcalcifications Benign Negative 
51 L C 2 2 Presence of metallic marker Benign Positive 
54 R A 2 2 Microcalcifications Benign Positive 
77 R D - 5 17 mm mass Malignant Positive 
61 
R C 4 - Multifocal lobular type suspected carcinoma 
(MRI BI-RADS 4) 
Malignant Positive 
L 
C 2 - 
Macrocalcification and Focal contrast enh. 
(MRI BI-RADS 3) 
Not available Positive 
50 L B 2 2  10 mm mass Benign Positive 
67 L C 4 - Microcalcifications Malignant Negative 
49 L A 3 - Microcalcifications Benign Positive 
70 L D 3 4 Mass Malignant Positive 
42 L C 2 3  7 mm mass, hypoechoic Benign Negative 
67 L B 3 -    Architectural distortion  Benign Positive 
56 R B 4 4  31 mm mass, hypoechoic, irregular borders Malignant Positive 
43 R D 1 3  12 mm mass Benign Positive 
51 L C 3 - Microcalcifications Benign Positive 
59 L B - 4  11 mm areolar, suspicious of malignancy Malignant Positive 
40 L D 2 2  30 mm mass Benign Positive 
35 R C 2 3  7 mm, hypoechoic Benign Positive 
37 L A 2 3  25 mm mass Benign Negative 
43 R B 3 2 Microcalcifications Malignant Negative 
54 R B 2 2  18 mm mass Benign Negative 
49 L A 2 3  16 mm mass Benign Positive 
56 L D 4 4  27 mm mass Malignant Positive 
63 L A 3 4  6 mm mass Malignant Positive 
55 
R C 4 4  23 mm mass Malignant Positive 
L C 2 2 Multiple cysts Benign Positive 
64 R B 3 -  1.6 mm   microcalcifications Benign Negative 
37 
R - - 3  15.4 mm mass Benign Positive 
L - - 2 Multiple cysts Not available Positive 
76 R - - 3  13 mm  mass Malignant Negative 
45 R B 4 4  14 mm mass Malignant Positive 
72 L B 4 4  22 mm  mass Malignant Positive 
57 L - - 4  14 mm mass Malignant Negative 
20 L - - 2  16 mm  mass Benign Negative 
46 R B 2 2  12 mm mass Benign Positive 
78 
L A - 4  18 mm mass, hypoechoic Malignant Positive 
R A 3 2 Microcalcifications Not available Positive 
62 R B 4 - Opacity Malignant Negative 
44 L B 3 3  24 mm  mass Benign Positive 
57 R A 3 - Opacity  Benign Positive 
63 R A 3 - Opacity Benign Negative 
40 
L D 1 2  33 mm mass Benign Positive 
R D 1 2  Two masses: 7 mm and 22 mm, hypoechoic Benign Positive 






Table 4. List of the selected features for the selected conductivity weighed images. For each feature, we indicate: the mean and 
standard deviation for the NF breasts; the mean and standard deviation for the WF breasts; the decision offset corresponding to 
TN=0.55; Welch's t-test score and p-value; the AUC. 
 
 
 Mean(NF) Std(NF) Mean(WF) Std(WF) Doffset t-test  p-value AUC 
         
σ=0.3 S/m         
'VAR_p' 0.152 0.070 0.201 0.085 0.144 1 0.0019 0.68 
'MAD0_p' 0.308 0.073 0.353 0.077 0.305 1 0.0056 0.66 
'VAR_r' 1.115 0.604 1.397 0.612 1.060 1 0.0032 0.67 
'M2AVG_i' 2.143 0.320 2.317 0.350 2.124 1 0.0060 0.66 
         
σ=0.4 S/m         
'VAR_p' 0.216 0.081 0.275 0.107 0.201 1 0.0017 0.68 
'MAD0_p' 0.370 0.070 0.416 0.084 0.362 1 0.0037 0.66 
'VAR_r' 1.368 0.631 1.698 0.742 1.267 1 0.0035 0.66 
'M2AVG_i' 2.267 0.346 2.478 0.392 2.236 1 0.0049 0.66 
         
σ=0.5 S/m         
'VAR_p' 0.277 0.094 0.349 0.125 0.254 1 0.0008 0.69 
'MAD1_p' 0.358 0.076 0.401 0.090 0.339 1 0.0089 0.65 
'MAD0_r' 1.208 0.233 1.364 0.288 1.170 1 0.0024 0.67 
'KUR_i' 2.793 0.641 3.162 0.793 2.632 1 0.0034 0.67 
         
σ=0.6 S/m         
'VAR_p' 0.335 0.108 0.416 0.147 0.311 1 0.0016 0.68 
'M2AVG_i' 2.499 0.386 2.753 0.447 2.479 1 0.0035 0.68 
'MAX_p' 2.499 0.386 2.753 0.447 2.479 1 0.0035 0.66 
'ROS1_i' 2.548 0.392 2.805 0.453 2.530 1 0.0036 0.666 
         
σ=0.8 S/m         
'M2AVG_i' 2.700 0.420 2.981 0.491 2.654 1 0.0025 0.67 
'MAX_p' 2.700 0.420 2.981 0.491 2.654 1 0.0025 0.67 
'ROS1_i' 2.731 0.423 3.013 0.494 2.674 1 0.0027 0.67 






Six breasts are shown here in more details as six test cases, each one with three of the selected conductivity 
weighed microwave images (obtained for conductivities equal to 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). 
Figures 3 and 4 refer to NF breasts, while Figures 5-8 refer to WF breasts. Microwave images, normalized to 
unitary average of the intensity, are given here as 2D images in the azimuthal, i.e. coronal, plane; the images 
are divided into four quadrants corresponding to breast Upper-Outer (UO) quadrant; Upper-Inner (UI) 
quadrant; Lower-Outer (LO) quadrant; Lower-Inner (LI) quadrant.  Moreover, 1D intensity projection on X 
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and Y is displayed in the inserts. X and Y are given in meters; intensity is in arbitrary units. In each figure, 
the tables given as inserts of microwave images show the values of the correspondent selected features; in 
the same tables, for each feature we also report the binary score S in brackets, calculated from eq. (3). 
For each one of the six test cases, the output and main findings of the radiologist study review, with the 
correspondent conventional images, is also given. BI-RADS categories are also given for WF breasts. In 
more details, Figures 5 and 6 refer to breasts with microcalcifications and for both cases the final assessment 
is benign lesion; Figure 7 refers to breast with suspected carcinoma and the final assessment is malignant 
lesion; Figure 8 refers to breast with a macro-calcification and focal contrast enhancement (the final 
assessment is not available).  
Performances of the rule-of-thumb introduced above are evaluated empirically, after setting M=2 and N=3. 
We obtain a sensitivity of 38/51 ~ 74% (which increases to 18/22 ~ 82% when considering dense breasts 
only, i.e. ACR C and ACR D), with a specificity of 32/52 ~ 62%. Sensitivity performances of the rule-of-
thumb are summarized in Table 5, while the performance details for each one of the 51 WF breasts can be 
found in the last column of Table 3. In Table 5, MammoWave rule-of-thumb sensitivity is given also for 
benign and malignant findings, separately; specifically, for benign findings we obtain a sensitivity of 21/30 ~ 
70% (which increases to 11/14 ~ 78% when considering dense breasts only) while for malignant findings we 
obtain a sensitivity of 12/17 ~ 71% (which increases to 6/7 ~ 85% when considering dense breasts only). 
 
 
Table 5. MammoWave rule-of-thumb sensitivity is summarized (second row) for the WF breasts (both full set and dense breasts 
only): sensitivity is expressed as numerator/denominator (where the numerator represents the number of rule-of-thumb positive 
identification and the denominator represents the total number of WF breasts) and in percentages (given in brackets and rounded to 
nearest whole number).  
 Similarly, MammoWave rule-of-thumb sensitivity is summarized for benign (third row) and malignant (fourth row) findings, 
separately (both full set and dense breasts only). 
 
 
 MammoWave rule-of-thumb 
sensitivity 
MammoWave rule-of-thumb 
sensitivity: dense breasts only 
all WF breasts 38/51 (74%) 18/22 (82%) 
benign finding 21/30 (70%) 11/14 (78%) 






Figure 3. The radiologist study review “NF” for this scattered area of fibroglandular density (ACR B) breast has been obtained with 
the support of mammography images given in the bottom row.  
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.  
All microwave images show a quite homogeneous behavior. The binary score S (given in the inserted tables) is 0 for the all the 
features. The proposed rule-of-thumb classifies this breast as negative. 
 
Figure 4. The radiologist study review “NF” for this heterogeneously dense (ACR C) breast has been obtained with the support of 
mammography images given in the bottom row.  
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.  
All microwave images show a quite homogeneous behavior. The binary score S (given in the inserted tables) is 0 for the all the 
features. The proposed rule-of-thumb classifies this breast as negative. 
 
Figure 5. The radiologist study review “WF” for this heterogeneously dense (ACR C) breast has been obtained with the support of 
mammography images given in the bottom row, giving as output the presence of microcalcifications of 1.6 mm. The Echography  BI-
RADS is 1 and the Mammography BI-RADS is 2. The final assessment is benign lesion. 
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.  
All microwave images show a non-homogeneous behavior, with a main peak indicated by the red arrows. The binary score S (given 
in the inserted tables) is 1 for the all the features. The proposed rule-of-thumb classifies this breast as positive. 
 
Figure 6. The radiologist study review “WF” for this heterogeneously dense (ACR C) breast has been obtained with the support of 
mammography images given in the bottom row, giving as output the presence of a cluster of microcalcifications. The Mammography 
is BI-RADS 4. The final assessment is benign lesion. 
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.  
All microwave images show a non-homogeneous behavior, with a main peak indicated by the red arrows. From the binary score S 
(given in the inserted tables) we note that the number of occurrences of “1” is three when σ=0.3 S/m, one when σ=0.4 S/m and one 
when σ=0.5 S/m.  The proposed rule-of-thumb classifies this breast as positive. 
 
Figure 7. The radiologist study review “WF” for this heterogeneously dense (ACR C) breast has been obtained with the support of 
mammography and MRI images given in the bottom row, giving as output the presence of a suspected Special Type (ST) carcinoma, 
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multifocal lobular type. The Mammography BI-RADS is 4 and the Magnetic Resonance Imaging (MRI) BI-RADS is 4. The final 
assessment is malignant lesion. 
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.   
All microwave images show a non-homogeneous behavior, with a main peak indicated by the red arrows. From the binary score S 
(given in the inserted tables) we note that the number of occurrences of “1” is four when σ=0.3 S/m, four when σ=0.4 S/m and three 
when σ=0.5 S/m.  The proposed rule-of-thumb classifies this breast as positive. 
 
Figure 8. The radiologist study review “WF” for this heterogeneously dense (ACR C) breast has been obtained with the support of 
mammography and MRI images given in the bottom row, giving as output the presence of a macro-calcification and a focal contrast 
enhancement. The Mammography BI-RADS is 2 and the Magnetic Resonance Imaging (MRI) BI-RADS is 3. The final assessment is 
not available. 
Microwave images, normalized to unitary average of the intensity, are given in the top row for three different conductivity weighting 
(from left to right: 0.3 S/m, 0.4 S/m and 0.5 S/m, respectively). X and Y are given in meters; intensity is in arbitrary units.  
All microwave images show a non-homogeneous behavior, with a main peak indicated by the red arrows; a slightly lower peak in the 
same quadrant may be also noted. The binary score S (given in the inserted tables) is 1 for the all the features. The proposed rule-of-




Discussion and Conclusion 
Microwave images obtained using the proposed apparatus are intensity maps, given in linear arbitrary units, 
representing the homogeneity of breast’s dielectric properties. MammoWave does not use any patient-
specific estimation, which means that breast images are generated without any prior knowledge of patient-
specific breast dielectric properties. In more details, the images have been obtained using free space 
dielectric constant in eq. (1). Concerning the conductivity, for each breast we produced ten different 
microwave images by varying the conductivity from 0 to 0.9 S/m (in agreement with the breast conductivity 
average values reported in [10]). 
From visual inspection of microwave images, it can be pointed out that microwave images of WF breasts 
have a more non-homogenous behaviour with respect to NF breast. This confirms what was previously 
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highlighted in [15, 16], also through the use of phantom measurements, i.e. the contrast in dielectric 
properties between breast lesions and the surrounding tissues generates a peak in microwave images.  
Interestingly, small microcalcifications (1.6 mm) also lead to non-homogenous behaviour which can be 
visually appreciated.  
With the aim of discriminating between WF and NF breasts, some dedicated features have been introduced 
and selected. Such features allow a quantification of the non-homogeneity of the microwave images: some of 
them describe the entire image [15, 16], while others describe the peak region [23]. From Table 4, it is 
possible to verify that p-values of all the selected features are <0.001; thus, it follows that selected features 
are statistically robust in discriminating between WF and NF breasts. False Discovery Rate (FDR) correction 
for multiple comparisons may also be applied to the statistical tests: we verified that this leads to a slight 
increase of the p-values for the selected features, which remain statistically robust in discriminating between 
WF and NF breasts. Yet, from Table 4 it is clear that overlap exists among WF and NF breasts features. 
AUC of selected features span from 0.65 to 0.69. In addition, we also calculated AUCs of the selected 
features when considering dense breasts only, noting an increase up to 0.77. 
The binary score S operating on the combination of features may be used for establishing an empirical rule-
of-thumb allowing breast assessment; the underlying idea is that a “large number of occurrences of 1” may 
indicate a WF breast, while a “large number of occurrences of 0” may indicate a NF breast. From the 
examples given here, it can be noted that microcalcifications in an ACR C breast may have a “large number 
of occurrences of 1” in microwave images with lower conductivity weighting. Conversely, a carcinoma in an 
ACR C breast have a “large number of occurrences of 1” also in microwave images with higher conductivity 
weighting. Indeed, also from visual inspection it can be seen that a carcinoma in an ACR C may be better 
highlighted in microwave images with higher conductivity weighting. It follows that the use of a range of 
conductivity weighting when generating microwave images may be beneficial in detecting different kinds of 
lesions.   
Performances of the proposed rule-of-thumb have been evaluated by empirically calculating the sensitivity 
(after setting M=2 and N=3), obtaining an overall value of 74%, with a specificity of 62%. Sensitivity 
increases to an overall value of 82% when considering dense breasts only. From the results obtained when 
considering benign and malignant findings, separately, it appears that MammoWave sensitivity is similar for 
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both benign and malignant lesions, i.e. 70% and 71%, respectively (it should be noted that such values are 
lower than the overall value, since in 4 cases the final assessment is not available). Higher breast density has 
a positive impact in detection, increasing MammoWave sensitivity for both benign and malignant lesions to 
78% and 85%, respectively. These values are in agreement with [12, 13], where symptomatic patients only 
have been recruited; specifically, it is reported that sensitivity is 74% and 76% for benign and malignant 
lesions, respectively, and it increases to 79% (in both benign and malignant lesions) when considering dense 
breasts [13].  
A patient-specific knowledge of dielectric properties may lead to a further improvement in 
sensitivity/specificity [23, 24], By comparing the performances of the proposed rule-of-thumb (which 
combines many features) with respect to single features ROC curves (given in Figure 2), we can appreciate 
an increase in sensitivity; this is in agreement with [25], where a multi-feature analysis of Magnetic 
Resonance breast images has been performed.  
A limitation of this investigation is that we did not consider pre-menstrual information of the subjects, due to 
such information not being available. A further limitation of this investigation is that, concerning rule-of-
thumb modality for breast assessment, the impact on detection capabilities of the features/methods selection 
procedure, number of selected features/methods as well as of features’ correlation has not been investigated. 
Specifically, the number of selected features, i.e. 4, and methods, i.e. 5, has been selected arbitrarily. 
Moreover, ROC curves have been empirically calculated. However, it should be emphasized that the main 
aims of this paper are: i) to verify if a selection of features obtained from a range of conductivity weighted 
microwave images may allow discriminating between NF and WF breasts; ii) to verify if an appropriate 
combination and use of microwave image features may achieve performance enhancement versus single 
feature. Finally, it should be pointed out that, for this study, each breast has its own correspondent output of 
the radiologist study review, which has been used here as gold standard for classification of the breast into 
two categories: NF and WF breast. Some details of the detected or suspected lesions (such as BI-RADS 
categories, sizes and notes) have been collected throughout the study and, thus, they are shown here, but they 
are not used in statistical analysis. 
Further work on MammoWave, which has recently received CE Mark (Conformité Européenne) approval, is 
ongoing and more clinical trials are planned with the aim of improving clinical evidence on the use of 
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microwave imaging in the breast screening pathway. In addition, while our main current goal is 
discriminating between NF and WF breasts, dedicated clinical trials are also planned for quantifying 
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